Trial Outcomes & Findings for Repair of Infected or Contaminated Hernias (NCT NCT00617357)

NCT ID: NCT00617357

Last Updated: 2015-12-01

Results Overview

Wound Events are defined as those events which occurred in the area of the hernia repair and the repair site, including seroma, hematoma, dehiscence, infection, abscess, fistula, and re-herniation.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

83 participants

Primary outcome timeframe

Postoperatively up to 24 months

Results posted on

2015-12-01

Participant Flow

83 subjects enrolled between Sep 2007 and Aug 2008 from 12 US sites and followed for 24 months following hernia repair

83 subjects were enrolled, 3 were not implanted, resulting in 80 subjects implanted with device (ITT group).

Participant milestones

Participant milestones
Measure
Strattice Tissue Matrix
Overall Study
STARTED
83
Overall Study
COMPLETED
67
Overall Study
NOT COMPLETED
16

Reasons for withdrawal

Reasons for withdrawal
Measure
Strattice Tissue Matrix
Overall Study
Lost to Follow-up
7
Overall Study
Death
5
Overall Study
insurance concerns
2
Overall Study
Withdrawal by Subject
1
Overall Study
Physician Decision
1

Baseline Characteristics

Repair of Infected or Contaminated Hernias

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
One Arm
n=80 Participants
Strattice Reconstructive Tissue Matrix
Age, Continuous
57 years
STANDARD_DEVIATION 14 • n=5 Participants
Sex: Female, Male
Female
33 Participants
n=5 Participants
Sex: Female, Male
Male
47 Participants
n=5 Participants
Race/Ethnicity, Customized
Caucasian
71 participants
n=5 Participants
Race/Ethnicity, Customized
Black or African American
9 participants
n=5 Participants
Race/Ethnicity, Customized
Unknown or Not Reported
0 participants
n=5 Participants

PRIMARY outcome

Timeframe: Postoperatively up to 24 months

Population: 80 patients were enrolled and received Strattice Reconstructive Tissue Matrix to support the repair and were included in the Intent to Treat (ITT) population.

Wound Events are defined as those events which occurred in the area of the hernia repair and the repair site, including seroma, hematoma, dehiscence, infection, abscess, fistula, and re-herniation.

Outcome measures

Outcome measures
Measure
One Arm
n=80 Participants
Strattice Reconstructive Tissue Matrix
Incidence of Wound Events
53 participants

SECONDARY outcome

Timeframe: Baseline

The AAS includes 13 items covering a broad sample of sedentary, movement-related and graded-intensity physical activities. Respondents are asked to rate the degree of difficulty performing each of these activities in the previous 24 hours on a 5-point scale from "No difficulty" to "Not able to do it." The AAS has three subscales: sedentary activities (items 1-4); ambulatory activities (items 6-8); work/exercise activities (items 11-13). The AAS total and subscale scores are numerically transformed to produce a range of 0-100, with higher values indicating greater functional activity.

Outcome measures

Outcome measures
Measure
One Arm
n=79 Participants
Strattice Reconstructive Tissue Matrix
Activities Assessment Scale (AAS)
69.2 units on a scale
Standard Deviation 21.45

SECONDARY outcome

Timeframe: 30 Days

The AAS includes 13 items covering a broad sample of sedentary, movement-related and graded-intensity physical activities. Respondents are asked to rate the degree of difficulty performing each of these activities in the previous 24 hours on a 5-point scale from "No difficulty" to "Not able to do it." The AAS has three subscales: sedentary activities (items 1-4); ambulatory activities (items 6-8); work/exercise activities (items 11-13). The AAS total and subscale scores are transformed to produce a range of 0-100, with higher values indicating greater functional activity.

Outcome measures

Outcome measures
Measure
One Arm
n=72 Participants
Strattice Reconstructive Tissue Matrix
Activities Assessment Scale (AAS)
70.3 units on a scale
Standard Deviation 19.47

SECONDARY outcome

Timeframe: 3 Months

The AAS includes 13 items covering a broad sample of sedentary, movement-related and graded-intensity physical activities. Respondents are asked to rate the degree of difficulty performing each of these activities in the previous 24 hours on a 5-point scale from "No difficulty" to "Not able to do it." The AAS has three subscales: sedentary activities (items 1-4); ambulatory activities (items 6-8); work/exercise activities (items 11-13). The AAS total and subscale scores are transformed to produce a range of 0-100, with higher values indicating greater functional activity.

Outcome measures

Outcome measures
Measure
One Arm
n=70 Participants
Strattice Reconstructive Tissue Matrix
Activities Assessment Scale (AAS)
78.2 units on a scale
Standard Deviation 16.06

SECONDARY outcome

Timeframe: 6 Months

The AAS includes 13 items covering a broad sample of sedentary, movement-related and graded-intensity physical activities. Respondents are asked to rate the degree of difficulty performing each of these activities in the previous 24 hours on a 5-point scale from "No difficulty" to "Not able to do it." The AAS has three subscales: sedentary activities (items 1-4); ambulatory activities (items 6-8); work/exercise activities (items 11-13). The AAS total and subscale scores are transformed to produce a range of 0-100, with higher values indicating greater functional activity.

Outcome measures

Outcome measures
Measure
One Arm
n=73 Participants
Strattice Reconstructive Tissue Matrix
Activities Assessment Scale (AAS)
85.3 units on a scale
Standard Deviation 14.17

SECONDARY outcome

Timeframe: 12 Months

The AAS includes 13 items covering a broad sample of sedentary, movement-related and graded-intensity physical activities. Respondents are asked to rate the degree of difficulty performing each of these activities in the previous 24 hours on a 5-point scale from "No difficulty" to "Not able to do it." The AAS has three subscales: sedentary activities (items 1-4); ambulatory activities (items 6-8); work/exercise activities (items 11-13). The AAS total and subscale scores are transformed to produce a range of 0-100, with higher values indicating greater functional activity.

Outcome measures

Outcome measures
Measure
One Arm
n=66 Participants
Strattice Reconstructive Tissue Matrix
Activities Assessment Scale (AAS)
83.5 units on a scale
Standard Deviation 17.10

SECONDARY outcome

Timeframe: 24 Months

The AAS includes 13 items covering a broad sample of sedentary, movement-related and graded-intensity physical activities. Respondents are asked to rate the degree of difficulty performing each of these activities in the previous 24 hours on a 5-point scale from "No difficulty" to "Not able to do it." The AAS has three subscales: sedentary activities (items 1-4); ambulatory activities (items 6-8); work/exercise activities (items 11-13). The AAS total and subscale scores are transformed to produce a range of 0-100, with higher values indicating greater functional activity.

Outcome measures

Outcome measures
Measure
One Arm
n=60 Participants
Strattice Reconstructive Tissue Matrix
Activities Assessment Scale (AAS)
82.0 units on a scale
Standard Deviation 17.53

Adverse Events

Strattice

Serious events: 50 serious events
Other events: 20 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Strattice
n=80 participants at risk
Gastrointestinal disorders
Abdominal Pain
1.2%
1/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Abdominal abscess
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Abdominal wall abscess
2.5%
2/80 • Number of events 3
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Abdominal wound dehiscence
2.5%
2/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Anastomotic leak
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Vascular disorders
Arteriosclerosis obliterans
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Ascites
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Cardiac disorders
Atrial fibrillation
3.8%
3/80 • Number of events 3
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Bacteraemia
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Cardiac disorders
Cardiac arrest
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Catheter site infection
1.2%
1/80 • Number of events 3
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Hepatobiliary disorders
Cholecyctitis
2.5%
2/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Hepatobiliary disorders
Cholecyctitis chronic
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Investigations
Clostridium difficile toxin test positive
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Colostomy infection
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Constipation
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Cardiac disorders
Coronary artery disease
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Metabolism and nutrition disorders
Dehydration
3.8%
3/80 • Number of events 5
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Psychiatric disorders
Delirium
2.5%
2/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Dysphagia
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Folliculitis
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Gastroenteritis
2.5%
2/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Gastrointestinal haemorrhage
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Gastrointestinal stoma complication
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Renal and urinary disorders
Haematuria
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Renal and urinary disorders
Hydronephrosis
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Metabolism and nutrition disorders
Hypokalaemia
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Vascular disorders
Hypotension
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Iatrogenic injury
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Ileus
6.2%
5/80 • Number of events 5
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Ileus paralytic
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Incision site haematoma
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Incisional hernia
8.8%
7/80 • Number of events 7
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Intestinal obstruction
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Blood and lymphatic system disorders
Leukocytosis
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Metabolism and nutrition disorders
Metabolic disorder
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Multiple myeloma
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Cardiac disorders
Myocardial infarction
2.5%
2/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Osteomyelitis
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Pancreatic fistula
1.2%
1/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Pancreatitis
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Pelvic abscess
2.5%
2/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Vascular disorders
Peripheral ischaemia
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Pneumonia
2.5%
2/80 • Number of events 3
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Post procedural fistula
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Postoperative respiratory distress
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Postoperative wound infection
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Respiratory, thoracic and mediastinal disorders
Pulmonary embolism
3.8%
3/80 • Number of events 3
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Renal and urinary disorders
Renal failure acute
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Respiratory, thoracic and mediastinal disorders
Respiratory distress
1.2%
1/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Road traffic accident
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Sepsis
2.5%
2/80 • Number of events 2
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Seroma
5.0%
4/80 • Number of events 4
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Small bowel obstruction
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Small intestinal obstruction
3.8%
3/80 • Number of events 6
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Small intestinal stenosis
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Suture related complication
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Urinary tract infection
5.0%
4/80 • Number of events 4
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Gastrointestinal disorders
Vomiting
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Wound abscess
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Injury, poisoning and procedural complications
Wound complication
1.2%
1/80 • Number of events 1
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)
Infections and infestations
Wound infection
11.2%
9/80 • Number of events 11
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)

Other adverse events

Other adverse events
Measure
Strattice
n=80 participants at risk
Injury, poisoning and procedural complications
Seroma
25.0%
20/80 • Number of events 23
The at risk population was comprised of 80 subjects who received Strattice reinforcement of hernia repair (ITT population)

Additional Information

Dr Michael Franz

LifeCell

Phone: 908 947 1100

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place